RenovoRx is featured in the February 2013 issue of START-UP, an Elsevier Business Intelligence publication of in-depth profiles of leading-edge companies and technologies, including the most important new trends in the biopharma, medtech and diagnostics industries. Full access to the article is available online on START-UP’s website.
RenovoRx to Report Third Quarter 2026 Financial Results and Business Highlights on November 5, 2026
RenovoRx today announced that it will release third quarter 2026 financial results and business highlights after market close on Thursday, November 5, 2026, and host a conference call and webcast at 4:30 p.m. ET.